Does TOBRAMYCIN Cause Bronchial secretion retention? 21 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 21 reports of Bronchial secretion retention have been filed in association with TOBRAMYCIN (TOBRAMYCIN). This represents 0.2% of all adverse event reports for TOBRAMYCIN.
21
Reports of Bronchial secretion retention with TOBRAMYCIN
0.2%
of all TOBRAMYCIN reports
0
Deaths
14
Hospitalizations
How Dangerous Is Bronchial secretion retention From TOBRAMYCIN?
Of the 21 reports, 14 (66.7%) required hospitalization.
Is Bronchial secretion retention Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TOBRAMYCIN. However, 21 reports have been filed with the FAERS database.
What Other Side Effects Does TOBRAMYCIN Cause?
Off label use (1,467)
Death (888)
Cough (738)
Dyspnoea (706)
Pneumonia (700)
Hospitalisation (688)
Condition aggravated (669)
Cystic fibrosis (646)
Infective pulmonary exacerbation of cystic fibrosis (504)
Drug ineffective (453)
What Other Drugs Cause Bronchial secretion retention?
ALBUTEROL (374)
TIOTROPIUM (295)
PREDNISONE (268)
MONTELUKAST (240)
MEPOLIZUMAB (209)
BUDESONIDE (182)
OMALIZUMAB (171)
FUROSEMIDE (169)
BISOPROLOL (163)
BUDESONIDE\FORMOTEROL (156)
Which TOBRAMYCIN Alternatives Have Lower Bronchial secretion retention Risk?
TOBRAMYCIN vs TOBRAMYCIN\TOBRAMYCIN
TOBRAMYCIN vs TOCILIZUMAB
TOBRAMYCIN vs TOCILIZUMAB-AAZG
TOBRAMYCIN vs TOCOPHEROL
TOBRAMYCIN vs TOFACITINIB